Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RNF138 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | PHGDH | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | RIF1 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | DNASE1L1 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
mRNA | UBQLN4 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | PITPNB | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | PTMA | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | PARP2 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | LAMA5 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
mRNA | TMA16 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |